The maker of Nurofen has been fined over four million euro in Australia for misleading consumers.

The British company marketed four different painkillers as "targeting" migraines, headaches, back and period pain - but all four were identical to its standard product.

A regulator found the only difference was the packaging.

They were also double the price.